Lam Therapeutics, Inc.
Records under this name other than patents Lam Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Lam Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,307,370 | Rapamycin for the Treatment of Lymphangioleiomyomatosis Formerly held In force · High confidence | In force | High confidence | |
| US 10,307,371 | Rapamycin for the Treatment of Lymphangioleiomyomatosis Formerly held In force · Low confidence | In force | Low confidence | |
| US 11,123,289 | Rapamycin for the Treatment of Lymphangioleiomyomatosis Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 12,171,874 | Rapamycin for the Treatment of Lymphangioleiomyomatosis Formerly held In force · Low confidence | In force | Low confidence | |
| US 11,744,797 | Rapamycin for the Treatment of Lymphangioleiomyomatosis Formerly held In force · Low confidence | In force | Low confidence | |
| US 10,179,135 | Apilimod Compositions and Methods for Using Same Formerly held In force · High confidence | In force | High confidence | |
| US 11,103,449 | An Inhalable Rapamycin Formulation for Treating Age-Related Conditions Formerly held In force · High confidence | In force | High confidence | |
| US 11,648,199 | Inhalable Rapamycin Formulation for Treating Age-Related Conditions Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,491,143 | Inhalable Rapamycin Formulation for the Treatment of Pulmonary Hypertension Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,206,910 | Apilimod for Use in the Treatment of Renal Cancer Formerly held In force · High confidence | In force | High confidence |